Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL

Marc S. Hoffman, MD, explains how to select the appropriate CAR T-cell therapy for each patient, and the barriers patients with R/R LBCL face in receiving CAR T-cell therapy, despite its high efficacy rate.

Related Videos
Jeffery Zonder, MD
Jeffery Zonder, MD
Abhinav Deol, MD
Veronika Bachanova, MD, PhD
Eunice Wang, MD
Craig Sauter, MD
Lisa A. Carey MD, ScM, FASCO
Patrick I. Borgen, MD
Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C)
Steven J. Chmura, MD, PhD
Related Content